Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Letter

    Determination of swertiamarin and amarogentin content and evaluation of antibacterial activity in Eastern Himalayan species of Swertia L.

    wadmin2By wadmin2December 2, 2013Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Tapojita Samaddara, Binay Chaubeya, Sumita Jhaa* and Timir Baran Jhab
    aDepartment of Botany, University of Calcutta, 35 Ballygunge Circular Road, Kolkata-700019, West Bengal, INDIA.
    bPG Department of Botany, Barasat Government College, 10 K.N.C. Road, Barasat, Kolkata 700124, West Bengal, INDIA.

    Pharmacognosy Communications,2013,3,4,64-70.
    DOI:10.5530/pc.2013.4.9
    Published:December 2013
    Type:Research Letter

    ABSTRACT

    Introduction: The genus Swertia is known to contain many bioactive compounds having pharmacological activities. Biochemical fingerprinting can be useful in screening elite populations within and between Swertia species. The present work reports the estimation of two important bioactive compounds: swertiamarin and amarogentin and the evaluation of antibacterial activities in different species of Swertia collected from Eastern Himalayan regions of India. Methods: Chromatography was performed using a CAMAG HPTLC system for estimation of swertiamarin and amarogentin in S. chirayita, S. bimaculata, S. dilatata, S. nervosa and S. paniculata, collected from different regions of Eastern Himalayas. Separation was carried out on thin-layer chromatography aluminium plates pre-coated with silica gel 60 F254, eluted with ethyl acetate-methanol-water (77:15:8 v/v/v). Antibacterial activity against selected human clinical pathogens was tested by the disc diffusion method. Results: This investigation reports for the first time, the presence of swertiamarin in S. dilatata which is conventionally considered as an adulterant species in the chirata trade. The high quantity of swertiamarin detected in S. bimaculata leaves (5.80%) of Mungpoo population suggests that this so called inferior species can be a potential and promising source of swertiamarin in herbal and pharmaceutical industries. Antibacterial activity against Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa was observed in swertiamarin and amarogentin and in the plant extracts. Conclusions: Synthesis of swertiamarin in reproductive shoots of S. bimaculata, S. nervosa, S. dilatata and S. paniculata may provide a new source of biomass for future use. Activity against selected bacteria tested revealed promising antibacterial potential of the extracts of Swertia.

    Keywords: Amarogentin, antibacterial activity, Eastern Himalayas, high performance thin layer chromatography, Swertia species, swertiamarin

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up